BackAyala Pharmaceuticals Overview

Ayala Pharmaceuticals Other Liabilities

Track Ayala Pharmaceuticals's other liabilities ($-3.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$-3.61M
↓ 44.27% YoYΔ $2.87M vs prior year quarter

Peer average

Loading

Ayala Pharmaceuticals Other Liabilities History

Loading

Ayala Pharmaceuticals vs. peers: Other Liabilities Comparison

Loading

Ayala Pharmaceuticals Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Ayala Pharmaceuticals (AYLA) FAQ

As of the most recent data (December 2022), AYLA shows a other liabilities of $-3.6M. That compares with $-6.5M in the prior-year period — up 44.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AYLA's other liabilities is now $-3.6M (was $-6.5M) — a 44.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ayala Pharmaceuticals is outperforming or lagging.

Tracking AYLA's other liabilities over time shows whether Ayala Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $-3.6M That compares with $-6.5M in the prior-year period — up 44.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Ayala Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $-3.6M) with ownership activity and broader fundamentals.

Ayala Pharmaceuticals's other liabilities is $-3.6M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.